Trobe JD, Laibson PR . Dystrophic changes in the anterior cornea. Arch Ophthalmol 1972; 87: 378–82.
Laibson PR . Microcystic corneal dystrophy. Trans Am Ophthalmol Soc 1976; 74: 488–531.
Galbavy EJ, Mobilia EF, Kenyon KR . Recurrent corneal erosions. Int Ophthalmol Clin 1984; 24: 107–31.
Wood TO . Recurrent erosion. Trans Am Ophthalmol Soc 1984; 82: 850–98.
Brown R, Bron A . Recurrent corneal erosion. Br J Ophthalmol 1976; 60: 84–96.
Williams R, Buckley RJ . Pathogenesis and treatment of recurrent erosion. Br J Ophthalmol 1985; 69: 435–7.
Kenyon KR, Hersh PS, Starck T, Fogle JA . Corneal dysgeneses, dystrophies and degenerations. In: Tasman W, Jaeger EA, editors. Duane's clinical ophthalmology, vol. 4. Philadelphia/New York: Lippincott/Raven, 1997:chap 16: 8–14.
Heyworth P, Morlet N, Rayner S, Hykin P, Dart J . Natural history of recurrent erosion syndrome: a 4 year review of 117 patients. Br J Ophthalmol 1998; 82: 26–8.
Hope-Ross MW, Chell PB, Kervick GN, McDonnell PJ . Recurrent corneal erosion: clinical features. Eye 1994; 8: 373–7.
Hope-Ross MW, Chell PB, Kervick GN, McDonnell PJ . Oral tetracycline in the treatment of recurrent corneal erosions. Eye 1994; 8: 384–8.
Doughtery JM, McCully JP, Silvany RE, Meyer DR . The role of tetracycline in chronic blepharitis: inhibition of lipase production in staphylococci. Invest Ophthalmol Vis Sci 1991; 32: 2970–5.
Duly PN, Mackie IA . Distribution of tetracycline in the conjunctiva of patients on long-term systemic doses. Br J Ophthalmol 1985; 69: 25–8.
Perry HD, Kenyon KR, Lamberts DW, Foulks GN, Seedon JA, Golub LM . Systemic tetracycline hydrochloride as adjunctive therapy in the treatment of persistent epithelial defects. Ophthalmology 1986; 93: 1320–2.
Perry HD, Golub LM . Systemic tetracyclines in the treatment of non-infected corneal ulcers: a case report and proposed new mechanism of action. Ann Ophthalmol 1985; 17: 742–4.
Golub LM, Suomalainen K, Sorsa T . Host modulation with tetracyclines and their chemically modified analogues. Curr Opin Dentist 1992; 2: 80–90.
Cokington CD, Hyndiuk RA . Insights from experimental data on ciprofloxacin in the treatment of bacterial keratitis and ocular infections. Am J Ophthalmol 1991; 112(Suppl): S25–8.
Leibowitz HM . Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. Am J Ophthalmol 1991; 112(Suppl): S34–47.
About this article
Cite this article
McElvanney, A. Hypopyon keratitis in corneal epithelial basement membrane dystrophy. Eye 13, 585–586 (1999). https://doi.org/10.1038/eye.1999.144